Correlation Between ABVC Biopharma and Rezolute

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Rezolute at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Rezolute into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABVC Biopharma and Rezolute, you can compare the effects of market volatilities on ABVC Biopharma and Rezolute and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Rezolute. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Rezolute.

Diversification Opportunities for ABVC Biopharma and Rezolute

0.29
  Correlation Coefficient

Modest diversification

The 3 months correlation between ABVC and Rezolute is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Rezolute in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rezolute and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Rezolute. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rezolute has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Rezolute go up and down completely randomly.

Pair Corralation between ABVC Biopharma and Rezolute

Given the investment horizon of 90 days ABVC Biopharma is expected to under-perform the Rezolute. In addition to that, ABVC Biopharma is 1.84 times more volatile than Rezolute. It trades about -0.04 of its total potential returns per unit of risk. Rezolute is currently generating about -0.01 per unit of volatility. If you would invest  469.00  in Rezolute on September 24, 2024 and sell it today you would lose (30.00) from holding Rezolute or give up 6.4% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

ABVC Biopharma  vs.  Rezolute

 Performance 
       Timeline  
ABVC Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ABVC Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Rezolute 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Rezolute has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Rezolute is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

ABVC Biopharma and Rezolute Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ABVC Biopharma and Rezolute

The main advantage of trading using opposite ABVC Biopharma and Rezolute positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Rezolute can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rezolute will offset losses from the drop in Rezolute's long position.
The idea behind ABVC Biopharma and Rezolute pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Equity Valuation
Check real value of public entities based on technical and fundamental data